Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Wilmington, Delaware


Purpose:

The purpose of this retrospective, non-interventional sutdy is to compare the effectiveness of ICS/LABA combination therapy in the reduction of COPD exacerbations during the 12 months after initiation of therapy between COPD patients who are adherent to the index medication and those who are non-adherent.


Study summary:

This retrospective, observational study will assess the effectiveness of ICS/LABA combination therapies among COPD patients new to the ICS/LABA combination therapies in the US, comparing those who are adherent to the index medication and those who are non-adherent. Adherence will be measured using the proportion of days covered with the index medication. Medical and pharmacy claims data will be used as the data source.


Criteria:

Inclusion Criteria: - at least one prescription fill for ICS/LABA combination during identification period. - COPD diagnosis - 40 years or older at index date - > or = 12 months of continuous health plan enrollment prior to and following index date - 1 or more prescription for SABA, SAMA or SABA/SAMA during the pre-index period. Exclusion Criteria: - Patients with prescription claim for ICS/LABA combination therapy during the 12 month pre-index period - Patients receiving oral corticosteroid medication for more than 180 days during the 12 month pre-index period - Patients with cancer diagnosis in 12 month pre-index period


NCT ID:

NCT02446041


Primary Contact:

Study Chair
Frank Trudo, MD
AstraZeneca


Backup Contact:

N/A


Location Contact:

Wilmington, Delaware
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.